Strides Pharma Global Pte Ltd Singapore has received approval from the US Food and Drug Administration (USFDA) for the medication, the company said in a statement. The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Symmetrel Capsules, 100 mg, of Endo Pharmaceuticals, Inc (Endo).
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/mJf45lT
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Strides Pharma arm gets USFDA nod to market Amantadine Hydrochloride Softgel Capsules in America
0 comments:
Post a Comment